Lipid Profile in People Starting Antiretroviral Therapy With Efavirenz or Dolutegravir Based Regimens from a Reference Center in Brazil: A Cohort Study. RSD 2022, 11 (5), e55811528662. https://doi.org/10.33448/rsd-v11i5.28662.